Cargando…
Factor quinolinone inhibitors disrupt spindles and multiple LSF (TFCP2)-protein interactions in mitosis, including with microtubule-associated proteins
Factor quinolinone inhibitors (FQIs), a first-in-class set of small molecule inhibitors targeted to the transcription factor LSF (TFCP2), exhibit promising cancer chemotherapeutic properties. FQI1, the initial lead compound identified, unexpectedly induced a concentration-dependent delay in mitotic...
Autores principales: | Yunes, Sarah A., Willoughby, Jennifer L. S., Kwan, Julian H., Biagi, Jessica M., Pokharel, Niranjana, Chin, Hang Gyeong, York, Emily A., Su, Kuan-Chung, George, Kelly, Shah, Jagesh V., Emili, Andrew, Schaus, Scott E., Hansen, Ulla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200292/ https://www.ncbi.nlm.nih.gov/pubmed/35704642 http://dx.doi.org/10.1371/journal.pone.0268857 |
Ejemplares similares
-
Factor quinolinone inhibitors alter cell morphology and motility by destabilizing interphase microtubules
por: Stoiber, Patrick, et al.
Publicado: (2021) -
Transcription factor LSF (TFCP2) inhibits melanoma growth
por: Goto, Yuji, et al.
Publicado: (2015) -
The microtubule-associated histone methyltransferase SET8, facilitated by transcription factor LSF, methylates α-tubulin
por: Chin, Hang Gyeong, et al.
Publicado: (2020) -
Targeting the oncogene LSF with either the small molecule inhibitor FQI1 or siRNA causes mitotic delays with unaligned chromosomes, resulting in cell death or senescence
por: Willoughby, Jennifer L. S., et al.
Publicado: (2020) -
Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC model
por: Rajasekaran, Devaraja, et al.
Publicado: (2015)